Catalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Core Insights - Catalyst Pharmaceuticals, Inc. is set to present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026, highlighting its focus on rare and difficult-to-treat diseases [1][2] Company Overview - Catalyst Pharmaceuticals is a commercial-stage biopharmaceutical company dedicated to in-licensing, developing, and commercializing innovative medicines for patients with rare diseases [3] - The company has a strong commitment to patient care, ensuring accessibility through a comprehensive suite of support services [3] - Catalyst has been recognized on the Forbes 2025 list as one of America's Most Successful Mid-Cap Companies and on the 2025 Deloitte Technology Fast 500™ list as one of North America's Fastest-Growing Companies [3]